Clinical trial
Multicenter, Randomized, Controlled, Prospective, Confirmatory Study to Evaluate the Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients Confidential Statement
NCT07003841 is registered in ClinicalTrials.gov with SKIA Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Randomized, Controlled, Prospective, Confirmatory Study to Evaluate the Clinical Efficacy of Augmented Reality (AR)-Based Breast Cancer Medical Imaging Solution (SKIA-Breast) Localization Method in Breast Cancer Patients Confidential Statement
- Lead sponsor
- SKIA Inc.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 19, 2025
- Completion date
- March 31, 2027
- Enrollment
- 94 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.